# Filing Detail

Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001698530-19-000030
Filing Date
2019-03-19
Accepted
2019-03-19 18:45:15
Documents
7

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 424B3 | a424b3prosupno8.htm | 424B3 | 2173009
2 |  | a201810kdevelopmentpipeline.jpg | GRAPHIC | 200049
3 |  | ast008breastcancer.jpg | GRAPHIC | 141436
4 |  | image95.jpg | GRAPHIC | 169998
5 |  | smainvivogreyscale.jpg | GRAPHIC | 107198
6 |  | twosnasa04.jpg | GRAPHIC | 299852
7 |  | xcur17preclinicalresults.jpg | GRAPHIC | 612610
| Complete submission text file | 0001698530-19-000030.txt |  | 4259100

Mailing Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077
Business Address 8045 LAMON AVE, SUITE 410 SKOKIE IL 60077 847-673-1700
EXICURE, INC. (Filer) CIK: 0001698530 (see all company filings)

EIN.: 815333008 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-221791 | Film No.: 19693048
SIC: 2834 Pharmaceutical Preparations